# IGI

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/igi

- Industry: Medical Devices & Equipment
- Headquarters: US
- Website: www.igilabs.com
- Total disclosed funding: $7.5M
- Latest round: Series C (Mar 31, 2010)
- Investors on record: 1

## About

IGI is a company focused on developing advanced online gaming platforms, specializing in engaging Slot777 experiences for players, ensuring high payout rates and security through innovative technology.IGI, headquartered in the US, operates primarily in the online gaming sector, offering a platform for slot games. The company has undergone significant strides in its business strategy since its inception, adapting to the evolving digital landscape. The leadership team includes CEOs Daniel Raz, Diana Lu, Dominique Bandet, and Javed Hassan. In March 2010, IGI raised USD 1.55 mn in Series C financing from Signet Healthcare Partners, marking a pivotal moment in its funding journey and bringing the total amount raised to USD 1.55 mn over 4 deals.IGI’s platform, BETKING88, specializes in high-quality Slot777 games, delivering a secure and engaging gaming experience. Utilizing advanced algorithms and security systems, it offers a wide range of slot games to individual players, primarily in Southeast Asia. Features such as Slot QRIS enhance transaction security and efficiency, catering to market demands.The company generates revenue through transaction-based income derived from player participation in its slot games. Players deposit funds to create accounts and engage in gaming activities, with the opportunity to win based on game outcomes. The direct-to-consumer model ensures that players have access to the platform directly, while promotional bonuses and in-game purchases further support revenue streams through player deposits and winnings payouts.IGI aims to leverage the USD 1.55 mn raised in its most recent funding round to further develop new gaming products and enhance its platform. There are plans to expand into additional geographical markets, specifically targeting regions in Southeast Asia by the end of 2012. The funds will be utilized to support these initiatives, focusing on product development and market entry strategies.

## Funding rounds

- Series C, Mar 31, 2010, $1.6M — Signet Healthcare Partners
- Series B, Mar 16, 2009, $6M — Signet Healthcare Partners

## Investors

- Signet Healthcare Partners (https://capitalatlas.ai/funds/signet-healthcare-partners) — Series B, Series C